Sarcoma Oncology Research Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Sarcoma Oncology Research Center sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Sarcoma Oncology Research Center: 8 sponsored US clinical trials, 5 recruiting.
Sarcoma Oncology Research Center sponsors 8 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 1 completed. 0 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Sarcoma, with 3 trials.
Upper-quartile sponsor footprint
Sarcoma Oncology Research Center sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid Tumors
NCT07671534
Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma
NCT04535271
GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma
NCT04535713
Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma
NCT03886311
SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma
NCT03138161
SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma
NCT03778996
Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors
NCT04165330
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
NCT03190174
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 5 |
What is open in the Sarcoma Oncology Research Center pipeline
5 recruiting of 8 indexed (63% open); 1 completed (13%).
Phase mix: 0 late (III/IV) vs 8 early (I/II) (early-phase heavy).
Top condition: Sarcoma (3 trials), 8 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Sarcoma Oncology Research Center: open-pipeline peers nationwide
Peers matched on 8 registered trials and 63% open enrollment, not the therapeutic-area sidebar.
Sarcoma Oncology Research Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 63% open enrollment (± trial volume)
- Canadian Cancer Trials Group · 63% recruiting · 16 trials
- CellSight Technologies · 63% recruiting · 8 trials
- Cook Children's Health Care System · 63% recruiting · 8 trials
- Nurix Therapeutics · 63% recruiting · 8 trials
Related
What to do with this Sarcoma Oncology Research Center page
8 registered trials is a research-attention snapshot, not an endorsement of Sarcoma Oncology Research Center or any single study.
- 5 of Sarcoma Oncology Research Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Sarcoma is the condition Sarcoma Oncology Research Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Sarcoma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Sarcoma Oncology Research Center pipeline card: 8 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.